US Patent 10407512 Bi-specific fusion proteins
Patent 10407512 was granted and assigned to Silver Creek Pharmaceuticals, Inc. on September, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10407512 Bi-specific fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
